nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenoxybenzamine—CYP3A4—Imiquimod—skin cancer	0.138	0.292	CbGbCtD
Phenoxybenzamine—CYP3A4—Temozolomide—skin cancer	0.138	0.292	CbGbCtD
Phenoxybenzamine—CYP3A4—Vismodegib—skin cancer	0.0958	0.202	CbGbCtD
Phenoxybenzamine—CYP3A4—Vemurafenib—skin cancer	0.0757	0.16	CbGbCtD
Phenoxybenzamine—CYP3A4—Docetaxel—skin cancer	0.026	0.0548	CbGbCtD
Phenoxybenzamine—Monobenzone—TYR—skin cancer	0.0235	0.845	CrCbGaD
Phenoxybenzamine—CALM2—ear—skin cancer	0.0135	0.0613	CbGeAlD
Phenoxybenzamine—CALM1—ear—skin cancer	0.0134	0.0611	CbGeAlD
Phenoxybenzamine—CALM2—nerve—skin cancer	0.00848	0.0386	CbGeAlD
Phenoxybenzamine—CALM1—nerve—skin cancer	0.00844	0.0384	CbGeAlD
Phenoxybenzamine—CALM2—endothelium—skin cancer	0.00722	0.0329	CbGeAlD
Phenoxybenzamine—CALM1—endothelium—skin cancer	0.00719	0.0327	CbGeAlD
Phenoxybenzamine—CALM2—hair follicle—skin cancer	0.0071	0.0323	CbGeAlD
Phenoxybenzamine—CALM2—blood vessel—skin cancer	0.00666	0.0303	CbGeAlD
Phenoxybenzamine—CALM1—blood vessel—skin cancer	0.00663	0.0302	CbGeAlD
Phenoxybenzamine—CALM3—nipple—skin cancer	0.00613	0.0279	CbGeAlD
Phenoxybenzamine—SLC22A3—nipple—skin cancer	0.00567	0.0258	CbGeAlD
Phenoxybenzamine—ADRA1D—epithelium—skin cancer	0.0053	0.0241	CbGeAlD
Phenoxybenzamine—CALM2—nipple—skin cancer	0.00482	0.0219	CbGeAlD
Phenoxybenzamine—CALM1—nipple—skin cancer	0.00479	0.0218	CbGeAlD
Phenoxybenzamine—CALM2—neck—skin cancer	0.00477	0.0217	CbGeAlD
Phenoxybenzamine—CALM1—neck—skin cancer	0.00474	0.0216	CbGeAlD
Phenoxybenzamine—ADRA2C—nipple—skin cancer	0.0043	0.0196	CbGeAlD
Phenoxybenzamine—SLC22A3—connective tissue—skin cancer	0.00402	0.0183	CbGeAlD
Phenoxybenzamine—ADRA1D—female reproductive system—skin cancer	0.00393	0.0179	CbGeAlD
Phenoxybenzamine—CALM3—mammalian vulva—skin cancer	0.00358	0.0163	CbGeAlD
Phenoxybenzamine—ADRA2A—nipple—skin cancer	0.00343	0.0156	CbGeAlD
Phenoxybenzamine—CALM2—connective tissue—skin cancer	0.00342	0.0155	CbGeAlD
Phenoxybenzamine—CALM1—connective tissue—skin cancer	0.0034	0.0155	CbGeAlD
Phenoxybenzamine—ADRA1B—head—skin cancer	0.00336	0.0153	CbGeAlD
Phenoxybenzamine—SLC22A3—mammalian vulva—skin cancer	0.00331	0.0151	CbGeAlD
Phenoxybenzamine—ADRA1D—head—skin cancer	0.00329	0.015	CbGeAlD
Phenoxybenzamine—CALM2—epithelium—skin cancer	0.00324	0.0148	CbGeAlD
Phenoxybenzamine—CALM1—epithelium—skin cancer	0.00323	0.0147	CbGeAlD
Phenoxybenzamine—CALM2—skin of body—skin cancer	0.00308	0.014	CbGeAlD
Phenoxybenzamine—CALM1—skin of body—skin cancer	0.00307	0.014	CbGeAlD
Phenoxybenzamine—ADRA1A—epithelium—skin cancer	0.00304	0.0138	CbGeAlD
Phenoxybenzamine—SLC22A3—female reproductive system—skin cancer	0.00284	0.0129	CbGeAlD
Phenoxybenzamine—CALM2—mammalian vulva—skin cancer	0.00281	0.0128	CbGeAlD
Phenoxybenzamine—CALM1—mammalian vulva—skin cancer	0.0028	0.0127	CbGeAlD
Phenoxybenzamine—ADRA2C—mammalian vulva—skin cancer	0.00251	0.0114	CbGeAlD
Phenoxybenzamine—CALM2—lymphoid tissue—skin cancer	0.0025	0.0114	CbGeAlD
Phenoxybenzamine—CALM1—lymphoid tissue—skin cancer	0.00249	0.0113	CbGeAlD
Phenoxybenzamine—SLC22A1—head—skin cancer	0.00248	0.0113	CbGeAlD
Phenoxybenzamine—ADRA2A—connective tissue—skin cancer	0.00244	0.0111	CbGeAlD
Phenoxybenzamine—CALM2—female reproductive system—skin cancer	0.00241	0.011	CbGeAlD
Phenoxybenzamine—CALM1—female reproductive system—skin cancer	0.0024	0.0109	CbGeAlD
Phenoxybenzamine—SLC22A3—head—skin cancer	0.00237	0.0108	CbGeAlD
Phenoxybenzamine—ADRA1A—lymphoid tissue—skin cancer	0.00234	0.0107	CbGeAlD
Phenoxybenzamine—Orphenadrine—SCN10A—skin cancer	0.00203	0.0731	CrCbGaD
Phenoxybenzamine—CALM2—head—skin cancer	0.00201	0.00916	CbGeAlD
Phenoxybenzamine—ADRA2A—mammalian vulva—skin cancer	0.00201	0.00913	CbGeAlD
Phenoxybenzamine—CALM1—head—skin cancer	0.002	0.00912	CbGeAlD
Phenoxybenzamine—ADRA1A—head—skin cancer	0.00189	0.00859	CbGeAlD
Phenoxybenzamine—ADRA2C—head—skin cancer	0.0018	0.00819	CbGeAlD
Phenoxybenzamine—CALM3—lymph node—skin cancer	0.00179	0.00817	CbGeAlD
Phenoxybenzamine—ADRA2A—female reproductive system—skin cancer	0.00172	0.00782	CbGeAlD
Phenoxybenzamine—SLC22A3—lymph node—skin cancer	0.00166	0.00755	CbGeAlD
Phenoxybenzamine—ADRA2A—head—skin cancer	0.00144	0.00653	CbGeAlD
Phenoxybenzamine—CALM2—lymph node—skin cancer	0.00141	0.00641	CbGeAlD
Phenoxybenzamine—CALM1—lymph node—skin cancer	0.0014	0.00638	CbGeAlD
Phenoxybenzamine—CYP3A4—female reproductive system—skin cancer	0.00135	0.00616	CbGeAlD
Phenoxybenzamine—Fenoprofen—PTGS2—skin cancer	0.00127	0.0458	CrCbGaD
Phenoxybenzamine—ADRA2C—lymph node—skin cancer	0.00126	0.00573	CbGeAlD
Phenoxybenzamine—Phenylbutazone—PTGS2—skin cancer	0.00102	0.0366	CrCbGaD
Phenoxybenzamine—ADRA2A—lymph node—skin cancer	0.001	0.00457	CbGeAlD
Phenoxybenzamine—ADRA2C—Signaling Pathways—FOXO4—skin cancer	8.79e-05	0.000315	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—SHH—skin cancer	8.76e-05	0.000314	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—RASA1—skin cancer	8.7e-05	0.000312	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—PTGER4—skin cancer	8.7e-05	0.000312	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by NGF—KRAS—skin cancer	8.68e-05	0.000311	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—FOXO4—skin cancer	8.65e-05	0.00031	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Hemostasis—NRAS—skin cancer	8.62e-05	0.000309	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by NGF—KRAS—skin cancer	8.4e-05	0.000301	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by NGF—KRAS—skin cancer	8.4e-05	0.000301	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—PTCH1—skin cancer	8.3e-05	0.000298	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—SMO—skin cancer	8.3e-05	0.000298	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—PLIN2—skin cancer	8.14e-05	0.000292	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—PTGER4—skin cancer	8.08e-05	0.00029	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—SHH—skin cancer	7.99e-05	0.000287	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Hemostasis—KRAS—skin cancer	7.94e-05	0.000285	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—RASA1—skin cancer	7.94e-05	0.000285	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—SHH—skin cancer	7.73e-05	0.000277	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—SHH—skin cancer	7.73e-05	0.000277	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Metabolism—ERCC2—skin cancer	7.7e-05	0.000276	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—FOXO4—skin cancer	7.68e-05	0.000276	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—RASA1—skin cancer	7.68e-05	0.000275	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—RASA1—skin cancer	7.68e-05	0.000275	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—PTCH1—skin cancer	7.58e-05	0.000272	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—SMO—skin cancer	7.58e-05	0.000272	CbGpPWpGaD
Phenoxybenzamine—CALM3—Neuronal System—HRAS—skin cancer	7.52e-05	0.00027	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Metabolism—ERCC2—skin cancer	7.49e-05	0.000269	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Hemostasis—KRAS—skin cancer	7.42e-05	0.000266	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by NGF—HRAS—skin cancer	7.38e-05	0.000265	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—PTGER4—skin cancer	7.38e-05	0.000264	CbGpPWpGaD
Phenoxybenzamine—SLC22A3—Metabolism—PTGS2—skin cancer	7.36e-05	0.000264	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—SMO—skin cancer	7.33e-05	0.000263	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—PTCH1—skin cancer	7.33e-05	0.000263	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—PTCH1—skin cancer	7.33e-05	0.000263	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—SMO—skin cancer	7.33e-05	0.000263	CbGpPWpGaD
Phenoxybenzamine—CALM1—Neuronal System—HRAS—skin cancer	7.28e-05	0.000261	CbGpPWpGaD
Phenoxybenzamine—CALM2—Neuronal System—HRAS—skin cancer	7.28e-05	0.000261	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—ERCC2—skin cancer	7.18e-05	0.000257	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—FOXO4—skin cancer	7.14e-05	0.000256	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by NGF—HRAS—skin cancer	7.14e-05	0.000256	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by NGF—HRAS—skin cancer	7.14e-05	0.000256	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—PTGER4—skin cancer	7.13e-05	0.000256	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—PTGER4—skin cancer	7.13e-05	0.000256	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by NGF—IL6—skin cancer	7.06e-05	0.000253	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Hemostasis—TP53—skin cancer	7.06e-05	0.000253	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Hemostasis—NRAS—skin cancer	7e-05	0.000251	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—TERT—skin cancer	6.96e-05	0.00025	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by NGF—IL6—skin cancer	6.83e-05	0.000245	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by NGF—IL6—skin cancer	6.83e-05	0.000245	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Hemostasis—HRAS—skin cancer	6.75e-05	0.000242	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—ERCC2—skin cancer	6.63e-05	0.000238	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Hemostasis—TP53—skin cancer	6.59e-05	0.000236	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—CSPG4—skin cancer	6.57e-05	0.000235	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—FOXO4—skin cancer	6.51e-05	0.000234	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—ERCC2—skin cancer	6.41e-05	0.00023	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—ERCC2—skin cancer	6.41e-05	0.00023	CbGpPWpGaD
Phenoxybenzamine—CALM3—Hemostasis—NRAS—skin cancer	6.39e-05	0.000229	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Hemostasis—HRAS—skin cancer	6.31e-05	0.000226	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—FOXO4—skin cancer	6.3e-05	0.000226	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—FOXO4—skin cancer	6.3e-05	0.000226	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—TERT—skin cancer	6.29e-05	0.000225	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—TERT—skin cancer	6.21e-05	0.000223	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—TERT—skin cancer	6.21e-05	0.000223	CbGpPWpGaD
Phenoxybenzamine—CALM2—Hemostasis—NRAS—skin cancer	6.18e-05	0.000222	CbGpPWpGaD
Phenoxybenzamine—CALM1—Hemostasis—NRAS—skin cancer	6.18e-05	0.000222	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—ERCC2—skin cancer	6.08e-05	0.000218	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Hemostasis—KRAS—skin cancer	6.03e-05	0.000216	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—TERT—skin cancer	6.01e-05	0.000216	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—TERT—skin cancer	6.01e-05	0.000216	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—TERT—skin cancer	5.87e-05	0.000211	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling by GPCR—NRAS—skin cancer	5.87e-05	0.00021	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—TERT—skin cancer	5.78e-05	0.000207	CbGpPWpGaD
Phenoxybenzamine—CALM3—Innate Immune System—NRAS—skin cancer	5.75e-05	0.000206	CbGpPWpGaD
Phenoxybenzamine—CALM2—Innate Immune System—NRAS—skin cancer	5.56e-05	0.000199	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—NRAS—skin cancer	5.56e-05	0.000199	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—ERCC2—skin cancer	5.55e-05	0.000199	CbGpPWpGaD
Phenoxybenzamine—CALM3—Adaptive Immune System—NRAS—skin cancer	5.52e-05	0.000198	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—BRAF—skin cancer	5.51e-05	0.000198	CbGpPWpGaD
Phenoxybenzamine—CALM3—Hemostasis—KRAS—skin cancer	5.5e-05	0.000197	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—ERCC2—skin cancer	5.37e-05	0.000193	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—ERCC2—skin cancer	5.37e-05	0.000193	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Hemostasis—TP53—skin cancer	5.36e-05	0.000192	CbGpPWpGaD
Phenoxybenzamine—CALM2—Adaptive Immune System—NRAS—skin cancer	5.34e-05	0.000192	CbGpPWpGaD
Phenoxybenzamine—CALM1—Adaptive Immune System—NRAS—skin cancer	5.34e-05	0.000192	CbGpPWpGaD
Phenoxybenzamine—CALM1—Hemostasis—KRAS—skin cancer	5.32e-05	0.000191	CbGpPWpGaD
Phenoxybenzamine—CALM2—Hemostasis—KRAS—skin cancer	5.32e-05	0.000191	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling by GPCR—NRAS—skin cancer	5.3e-05	0.00019	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling by GPCR—NRAS—skin cancer	5.23e-05	0.000187	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—TERT—skin cancer	5.13e-05	0.000184	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Hemostasis—HRAS—skin cancer	5.12e-05	0.000184	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling by GPCR—KRAS—skin cancer	5.05e-05	0.000181	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—BRAF—skin cancer	4.98e-05	0.000178	CbGpPWpGaD
Phenoxybenzamine—CALM3—Innate Immune System—KRAS—skin cancer	4.95e-05	0.000177	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling by GPCR—NRAS—skin cancer	4.95e-05	0.000177	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—BRAF—skin cancer	4.92e-05	0.000176	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—BRAF—skin cancer	4.91e-05	0.000176	CbGpPWpGaD
Phenoxybenzamine—CALM3—Hemostasis—TP53—skin cancer	4.89e-05	0.000175	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling by GPCR—NRAS—skin cancer	4.87e-05	0.000175	CbGpPWpGaD
Phenoxybenzamine—CALM2—Innate Immune System—KRAS—skin cancer	4.79e-05	0.000172	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—KRAS—skin cancer	4.79e-05	0.000172	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—TERT—skin cancer	4.77e-05	0.000171	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—BRAF—skin cancer	4.76e-05	0.000171	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—BRAF—skin cancer	4.76e-05	0.000171	CbGpPWpGaD
Phenoxybenzamine—CALM3—Adaptive Immune System—KRAS—skin cancer	4.75e-05	0.00017	CbGpPWpGaD
Phenoxybenzamine—CALM1—Hemostasis—TP53—skin cancer	4.73e-05	0.000169	CbGpPWpGaD
Phenoxybenzamine—CALM2—Hemostasis—TP53—skin cancer	4.73e-05	0.000169	CbGpPWpGaD
Phenoxybenzamine—CALM3—Hemostasis—HRAS—skin cancer	4.67e-05	0.000168	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—BRAF—skin cancer	4.65e-05	0.000167	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Metabolism—PTGS2—skin cancer	4.62e-05	0.000166	CbGpPWpGaD
Phenoxybenzamine—CALM2—Adaptive Immune System—KRAS—skin cancer	4.6e-05	0.000165	CbGpPWpGaD
Phenoxybenzamine—CALM1—Adaptive Immune System—KRAS—skin cancer	4.6e-05	0.000165	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—BRAF—skin cancer	4.58e-05	0.000164	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling by GPCR—KRAS—skin cancer	4.56e-05	0.000163	CbGpPWpGaD
Phenoxybenzamine—CALM2—Hemostasis—HRAS—skin cancer	4.52e-05	0.000162	CbGpPWpGaD
Phenoxybenzamine—CALM1—Hemostasis—HRAS—skin cancer	4.52e-05	0.000162	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling by GPCR—KRAS—skin cancer	4.5e-05	0.000161	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Metabolism—PTGS2—skin cancer	4.49e-05	0.000161	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—ENO2—skin cancer	4.46e-05	0.00016	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—TERT—skin cancer	4.35e-05	0.000156	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—NRAS—skin cancer	4.32e-05	0.000155	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—PTGS2—skin cancer	4.3e-05	0.000154	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling by GPCR—HRAS—skin cancer	4.29e-05	0.000154	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling by GPCR—KRAS—skin cancer	4.26e-05	0.000153	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—TERT—skin cancer	4.21e-05	0.000151	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—TERT—skin cancer	4.21e-05	0.000151	CbGpPWpGaD
Phenoxybenzamine—CALM3—Innate Immune System—HRAS—skin cancer	4.21e-05	0.000151	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling by GPCR—KRAS—skin cancer	4.19e-05	0.00015	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling by GPCR—IL6—skin cancer	4.11e-05	0.000147	CbGpPWpGaD
Phenoxybenzamine—CALM2—Innate Immune System—HRAS—skin cancer	4.07e-05	0.000146	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—HRAS—skin cancer	4.07e-05	0.000146	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—BRAF—skin cancer	4.06e-05	0.000146	CbGpPWpGaD
Phenoxybenzamine—CALM3—Adaptive Immune System—HRAS—skin cancer	4.04e-05	0.000145	CbGpPWpGaD
Phenoxybenzamine—CALM3—Innate Immune System—IL6—skin cancer	4.03e-05	0.000144	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—NRAS—skin cancer	4.02e-05	0.000144	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—PTGS2—skin cancer	3.97e-05	0.000143	CbGpPWpGaD
Phenoxybenzamine—CALM2—Adaptive Immune System—HRAS—skin cancer	3.91e-05	0.00014	CbGpPWpGaD
Phenoxybenzamine—CALM1—Adaptive Immune System—HRAS—skin cancer	3.91e-05	0.00014	CbGpPWpGaD
Phenoxybenzamine—CALM2—Innate Immune System—IL6—skin cancer	3.9e-05	0.00014	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—IL6—skin cancer	3.9e-05	0.00014	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling by GPCR—HRAS—skin cancer	3.87e-05	0.000139	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—PTGS2—skin cancer	3.85e-05	0.000138	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—PTGS2—skin cancer	3.85e-05	0.000138	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling by GPCR—HRAS—skin cancer	3.82e-05	0.000137	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—BRAF—skin cancer	3.78e-05	0.000135	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—KRAS—skin cancer	3.72e-05	0.000133	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling by GPCR—IL6—skin cancer	3.71e-05	0.000133	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—NRAS—skin cancer	3.67e-05	0.000131	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling by GPCR—IL6—skin cancer	3.66e-05	0.000131	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—PTGS2—skin cancer	3.65e-05	0.000131	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling by GPCR—HRAS—skin cancer	3.62e-05	0.00013	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling by GPCR—HRAS—skin cancer	3.56e-05	0.000128	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—NRAS—skin cancer	3.55e-05	0.000127	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—NRAS—skin cancer	3.55e-05	0.000127	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—NRAS—skin cancer	3.47e-05	0.000124	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling by GPCR—IL6—skin cancer	3.46e-05	0.000124	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—KRAS—skin cancer	3.46e-05	0.000124	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—BRAF—skin cancer	3.45e-05	0.000124	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling by GPCR—IL6—skin cancer	3.41e-05	0.000122	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—NRAS—skin cancer	3.35e-05	0.00012	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—BRAF—skin cancer	3.33e-05	0.00012	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—BRAF—skin cancer	3.33e-05	0.00012	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—PTGS2—skin cancer	3.33e-05	0.000119	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—NRAS—skin cancer	3.24e-05	0.000116	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—NRAS—skin cancer	3.24e-05	0.000116	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—PTGS2—skin cancer	3.22e-05	0.000115	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—PTGS2—skin cancer	3.22e-05	0.000115	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—HRAS—skin cancer	3.16e-05	0.000113	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—KRAS—skin cancer	3.16e-05	0.000113	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—NRAS—skin cancer	3.13e-05	0.000112	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—NRAS—skin cancer	3.09e-05	0.000111	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—NRAS—skin cancer	3.09e-05	0.000111	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—KRAS—skin cancer	3.05e-05	0.000109	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—KRAS—skin cancer	3.05e-05	0.000109	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—IL6—skin cancer	3.03e-05	0.000109	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—NRAS—skin cancer	2.99e-05	0.000107	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—NRAS—skin cancer	2.99e-05	0.000107	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—KRAS—skin cancer	2.98e-05	0.000107	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—HRAS—skin cancer	2.94e-05	0.000105	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—NRAS—skin cancer	2.92e-05	0.000105	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—KRAS—skin cancer	2.88e-05	0.000103	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—NRAS—skin cancer	2.88e-05	0.000103	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—IL6—skin cancer	2.81e-05	0.000101	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—KRAS—skin cancer	2.79e-05	0.0001	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—KRAS—skin cancer	2.79e-05	0.0001	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—KRAS—skin cancer	2.69e-05	9.65e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—HRAS—skin cancer	2.68e-05	9.62e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—KRAS—skin cancer	2.66e-05	9.54e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—KRAS—skin cancer	2.66e-05	9.53e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—TP53—skin cancer	2.65e-05	9.5e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—HRAS—skin cancer	2.59e-05	9.3e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—HRAS—skin cancer	2.59e-05	9.3e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—ERCC2—skin cancer	2.59e-05	9.29e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—KRAS—skin cancer	2.57e-05	9.23e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—KRAS—skin cancer	2.57e-05	9.23e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—IL6—skin cancer	2.57e-05	9.2e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—NRAS—skin cancer	2.55e-05	9.16e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—HRAS—skin cancer	2.53e-05	9.09e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—KRAS—skin cancer	2.52e-05	9.02e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—IL6—skin cancer	2.48e-05	8.9e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—IL6—skin cancer	2.48e-05	8.9e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—KRAS—skin cancer	2.48e-05	8.88e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—HRAS—skin cancer	2.45e-05	8.79e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—IL6—skin cancer	2.43e-05	8.7e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—TP53—skin cancer	2.39e-05	8.58e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—NRAS—skin cancer	2.37e-05	8.51e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—HRAS—skin cancer	2.37e-05	8.5e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—HRAS—skin cancer	2.37e-05	8.5e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—TP53—skin cancer	2.36e-05	8.47e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—IL6—skin cancer	2.35e-05	8.41e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—HRAS—skin cancer	2.29e-05	8.21e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—IL6—skin cancer	2.27e-05	8.14e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—IL6—skin cancer	2.27e-05	8.14e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—HRAS—skin cancer	2.26e-05	8.11e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—HRAS—skin cancer	2.26e-05	8.1e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—TP53—skin cancer	2.24e-05	8.02e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—TP53—skin cancer	2.2e-05	7.89e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—KRAS—skin cancer	2.2e-05	7.88e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—IL6—skin cancer	2.19e-05	7.85e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—HRAS—skin cancer	2.19e-05	7.85e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—HRAS—skin cancer	2.19e-05	7.85e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—NRAS—skin cancer	2.17e-05	7.77e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—IL6—skin cancer	2.17e-05	7.76e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—IL6—skin cancer	2.16e-05	7.75e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—HRAS—skin cancer	2.14e-05	7.67e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—HRAS—skin cancer	2.1e-05	7.54e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—NRAS—skin cancer	2.09e-05	7.51e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—NRAS—skin cancer	2.09e-05	7.51e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—IL6—skin cancer	2.09e-05	7.51e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—IL6—skin cancer	2.09e-05	7.51e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—IL6—skin cancer	2.05e-05	7.34e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—KRAS—skin cancer	2.04e-05	7.33e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—IL6—skin cancer	2.01e-05	7.22e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—TP53—skin cancer	1.95e-05	7.01e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—HRAS—skin cancer	1.87e-05	6.7e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—KRAS—skin cancer	1.86e-05	6.68e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—TP53—skin cancer	1.82e-05	6.51e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—KRAS—skin cancer	1.8e-05	6.47e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—KRAS—skin cancer	1.8e-05	6.47e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—IL6—skin cancer	1.79e-05	6.41e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—HRAS—skin cancer	1.74e-05	6.23e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—IL6—skin cancer	1.66e-05	5.96e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—TP53—skin cancer	1.66e-05	5.94e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—TP53—skin cancer	1.6e-05	5.75e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—TP53—skin cancer	1.6e-05	5.75e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—HRAS—skin cancer	1.58e-05	5.68e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—PTGS2—skin cancer	1.55e-05	5.57e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—HRAS—skin cancer	1.53e-05	5.5e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—HRAS—skin cancer	1.53e-05	5.5e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—IL6—skin cancer	1.52e-05	5.44e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—IL6—skin cancer	1.47e-05	5.26e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—IL6—skin cancer	1.47e-05	5.26e-05	CbGpPWpGaD
